Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

MCPIP1/Regnase-1 Restricts IL-17A- and IL-17C-Dependent Skin Inflammation.

Monin L, Gudjonsson JE, Childs EE, Amatya N, Xing X, Verma AH, Coleman BM, Garg AV, Killeen M, Mathers A, Ward NL, Gaffen SL.

J Immunol. 2017 Jan 15;198(2):767-775. doi: 10.4049/jimmunol.1601551. Epub 2016 Dec 5.

2.

MCPIP1 RNase Is Aberrantly Distributed in Psoriatic Epidermis and Rapidly Induced by IL-17A.

Ruiz-Romeu E, Ferran M, Giménez-Arnau A, Bugara B, Lipert B, Jura J, Florencia EF, Prens EP, Celada A, Pujol RM, Santamaria-Babí LF.

J Invest Dermatol. 2016 Aug;136(8):1599-1607. doi: 10.1016/j.jid.2016.04.030. Epub 2016 May 12.

3.

MCPIP1 Endoribonuclease Activity Negatively Regulates Interleukin-17-Mediated Signaling and Inflammation.

Garg AV, Amatya N, Chen K, Cruz JA, Grover P, Whibley N, Conti HR, Hernandez Mir G, Sirakova T, Childs EC, Smithgall TE, Biswas PS, Kolls JK, McGeachy MJ, Kolattukudy PE, Gaffen SL.

Immunity. 2015 Sep 15;43(3):475-87. doi: 10.1016/j.immuni.2015.07.021. Epub 2015 Aug 25.

4.

Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.

Johnston A, Fritz Y, Dawes SM, Diaconu D, Al-Attar PM, Guzman AM, Chen CS, Fu W, Gudjonsson JE, McCormick TS, Ward NL.

J Immunol. 2013 Mar 1;190(5):2252-62. doi: 10.4049/jimmunol.1201505. Epub 2013 Jan 28.

5.

IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.

Friedrich M, Tillack C, Wollenberg A, Schauber J, Brand S.

Inflamm Bowel Dis. 2014 Nov;20(11):1891-901. doi: 10.1097/MIB.0000000000000198.

PMID:
25299544
6.

Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.

Johansen C, Usher PA, Kjellerup RB, Lundsgaard D, Iversen L, Kragballe K.

Br J Dermatol. 2009 Feb;160(2):319-24. doi: 10.1111/j.1365-2133.2008.08902.x. Epub 2008 Oct 21.

PMID:
19016708
7.

Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.

van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E.

J Immunol. 2009 May 1;182(9):5836-45. doi: 10.4049/jimmunol.0802999.

8.

Psoriatic inflammation causes hepatic inflammation with concomitant dysregulation in hepatic metabolism via IL-17A/IL-17 receptor signaling in a murine model.

Al-Harbi NO, Nadeem A, Al-Harbi MM, Zoheir KMA, Ansari MA, El-Sherbeeny AM, Alanazi KM, Alotaibi MR, Ahmad SF.

Immunobiology. 2017 Feb;222(2):128-136. doi: 10.1016/j.imbio.2016.10.013. Epub 2016 Oct 18. Erratum in: Immunobiology. 2017 Dec;222(12):1081.

PMID:
27773660
9.

IL-17C and its receptor IL-17RA/IL-17RE identify human oral epithelial cell as an inflammatory cell in recurrent aphthous ulcer.

Al-Samadi A, Kouri VP, Salem A, Ainola M, Kaivosoja E, Barreto G, Konttinen YT, Hietanen J, Häyrinen-Immonen R.

J Oral Pathol Med. 2014 Feb;43(2):117-24. doi: 10.1111/jop.12095. Epub 2013 Jul 3.

PMID:
23834281
10.

CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.

Morimura S, Oka T, Sugaya M, Sato S.

J Dermatol Sci. 2016 Jun;82(3):175-88. doi: 10.1016/j.jdermsci.2016.03.004. Epub 2016 Mar 4.

PMID:
26976687
11.

Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.

Ma L, Xue H, Qi R, Wang Y, Yuan L.

J Transl Med. 2018 Mar 10;16(1):59. doi: 10.1186/s12967-018-1442-6.

12.

Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.

Huang SW, Chen YJ, Wang ST, Ho LW, Kao JK, Narita M, Takahashi M, Wu CY, Cheng HY, Shieh JJ.

J Dermatol Sci. 2016 Oct;84(1):59-70. doi: 10.1016/j.jdermsci.2016.07.007. Epub 2016 Jul 12.

PMID:
27449383
13.

Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.

Chen W, Gong Y, Zhang X, Tong Y, Wang X, Fei C, Xu H, Yu Q, Wang Y, Shi Y.

J Dermatol Sci. 2017 Feb;85(2):115-123. doi: 10.1016/j.jdermsci.2016.11.011. Epub 2016 Nov 28.

PMID:
27939414
14.

IL-17A plays a central role in the expression of psoriasis signature genes through the induction of IκB-ζ in keratinocytes.

Muromoto R, Hirao T, Tawa K, Hirashima K, Kon S, Kitai Y, Matsuda T.

Int Immunol. 2016 Sep;28(9):443-52. doi: 10.1093/intimm/dxw011. Epub 2016 Mar 3.

PMID:
26944069
15.

GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation.

Jones SA, Perera DN, Fan H, Russ BE, Harris J, Morand EF.

J Autoimmun. 2015 Jul;61:73-80. doi: 10.1016/j.jaut.2015.05.010. Epub 2015 Jun 13.

PMID:
26077873
16.

Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of imiquimod-induced psoriasis.

Sumida H, Yanagida K, Kita Y, Abe J, Matsushima K, Nakamura M, Ishii S, Sato S, Shimizu T.

J Immunol. 2014 May 1;192(9):4361-9. doi: 10.4049/jimmunol.1302959. Epub 2014 Mar 24.

17.

CIKS/Act1-mediated signaling by IL-17 cytokines in context: implications for how a CIKS gene variant may predispose to psoriasis.

Sønder SU, Paun A, Ha HL, Johnson PF, Siebenlist U.

J Immunol. 2012 Jun 15;188(12):5906-14. doi: 10.4049/jimmunol.1103233. Epub 2012 May 11.

18.

IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells.

Yoshiki R, Kabashima K, Honda T, Nakamizo S, Sawada Y, Sugita K, Yoshioka H, Ohmori S, Malissen B, Tokura Y, Nakamura M.

J Invest Dermatol. 2014 Jul;134(7):1912-1921. doi: 10.1038/jid.2014.98. Epub 2014 Feb 25.

19.

Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.

Kim JH, Choi YJ, Lee BH, Song MY, Ban CY, Kim J, Park J, Kim SE, Kim TG, Park SH, Kim HP, Sung YC, Kim SC, Shin EC.

J Allergy Clin Immunol. 2016 May;137(5):1466-1476.e3. doi: 10.1016/j.jaci.2015.11.021. Epub 2016 Jan 27.

PMID:
26824999
20.

Oral Administration of Vanillin Improves Imiquimod-Induced Psoriatic Skin Inflammation in Mice.

Cheng HM, Chen FY, Li CC, Lo HY, Liao YF, Ho TY, Hsiang CY.

J Agric Food Chem. 2017 Nov 29;65(47):10233-10242. doi: 10.1021/acs.jafc.7b04259. Epub 2017 Nov 14.

PMID:
29073354

Supplemental Content

Support Center